Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results

Detalles Bibliográficos
Autores principales: Coates, Laura C., Mease, Philip, Kronbergs, Andris, Helt, Cameron, Sandoval, David, Park, So Young, Combe, Bernard, Nash, Peter, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485082/
https://www.ncbi.nlm.nih.gov/pubmed/35821169
http://dx.doi.org/10.1007/s10067-022-06271-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485082/
https://www.ncbi.nlm.nih.gov/pubmed/35821169
http://dx.doi.org/10.1007/s10067-022-06271-3

Ejemplares similares